« Previous
Next »
Nuclear Medicine and Biology
Volume 33, Issue 2
, Pages 245-248
, February 2006
Noninvasive monitoring of colonic carcinogenesis: feasibility of [18F]FDG-PET in the azoxymethane model
References
- . Cancer statistics, 2001. [CA Cancer J Clin 2001;51(1):15] CA Cancer J Clin. 2001;51(2):144;[Erratum]
- . Incidence of colorectal carcinoma in the US — An update of trends by gender, race, age, subsite, and stage, 1975–1994. Cancer. 1999;85:1670–1676
- . Studies with the azoxymethane-rat preclinical model for assessing colon tumor development and chemoprevention. Environ Mol Mutagen. 2004;44:26–35
- . Oncological applications of FDG PET imaging: brain tumors, colorectal cancer lymphoma and melanoma. J Nucl Med. 1999;40:591–603
- . Dose response to a single injection of azoxymethane in rats. Induction of tumors in the gastrointestinal tract, auditory sebaceous glands, kidney, liver and preputial gland. Vet Pathol. 1975;12:165–177
- . Point: from animal models to prevention of colon cancer. Systematic review of chemoprevention in min mice and choice of the model system. Cancer Epidemiol Biomarkers Prev. 2003;12:391–400
- . Chemically induced carcinogenesis: a comparison of 1-methyl-1-nitrosourea, 7,12-dimethylbenzanthracene,diethylnitroso-amine and azoxymethan models (minireview). Endocr Regul. 2001;35:53–59
- The Vienna classification of gastrointestinal epithelial neoplasia. Gut. 2000;47:251–255
- F-18-FDG PET detection of colonic adenomas. J Nucl Med. 2001;42:989–992
- . 2-(18F)-Fluoro-2-deoxy-d-glucose positron emission tomography detects clinical relevant adenomas of the colon: a prospective study. J Clin Oncol. 2005;23:3713–3717
PII: S0969-8051(05)00277-5
doi: 10.1016/j.nucmedbio.2005.11.003
© 2006 Elsevier Inc. All rights reserved.
« Previous
Next »
Nuclear Medicine and Biology
Volume 33, Issue 2
, Pages 245-248
, February 2006
